ISPOR Europe 2024 Barcelone
ISPOR Europe 2024 Barcelone
Retrouvez nos posters de l’ISPOR Europe 2024 :
Market Access
- Analysis of the outcomes of the hearings of the transparency committee in France
- Evaluation of the early access program evolution: a three-year retrospective analysis
- Comparative analysis of medicines reimbursement in France : rare diseases versus other conditions
- Analysis of the reimbursement and pricing of vaccines in France
HEOR
- Unmet needs in high-risk non-muscle invasive and localized muscle invasive bladder cancer: a systematic literature review in the French setting
- Measuring fiscal impact as a component of productivity gain of prevention strategies in France
- How can discrete choice experiment method improve patient care and engagement : An example in the field of fertility
- Utility values for a cost-effectiveness model in france: a literature review on patients undergoing allogeneic haematopoietic stem cell transplantation
- Integrating the carbon footprint into economic modelling in france: the example of the healthcare pathway for chronic lymphocytic leukaemia
- Economic burden of hepatocellular carcinoma (HCC) treated with a curative resection or ablation (R/A) in France : LIVERPOOL study
RWE
- Healthcare resource use and costs of Hemophilia A (HA) in French adult patients in 2022: a nationwide Claims database analysis
- Healthcare resource use and costs of Hemophilia B (HB) in French adult patients in 2022: a nationwide Claims database analysis
- Real-world oral glucocorticoid use in systemic lupus erythematosus: a nation-wide population-based study using the french national medico-administrative database (LUPIN-F)
- Healthcare resource consumptions and costs of Myasthenia Gravis in France – the STAMINA study
- Burden of hospital candidemia in France: diagnostic performance of an administrative hospital database for case identification in a French University hospital